NL-OMON22287招募中不适用
Sequential FLAMSA chemotherapy and T cell depleted reduced intensity conditioning allogeneic stem cell transplantation with postponed donor lymphocyte infusion in elderly acute myeloid leukemia and high risk myelodysplasia patients
eiden University Medical Center0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with AML or high risk MDS (IPSS >= 1.5);
- •2. Not in remission after first intensive induction chemotherapy (morphologically > 5% blasts in bone marrow aspirate);
排除标准
- •1. Previous autologous or allogeneic SCT;
- •2. Acute promyelocytic leukemia;
研究者
相似试验
招募中
2 期
Sequential FLAMSA chemotherapy and T cell depleted reduced intensity conditioning allogeneic stem cell transplantation (TCD FLAMSA-RIC alloSCT) in elderly acute myeloid leukemia and high risk myelodysplasia patientsleukemiaNL-OMON39744eids Universitair Medisch Centrum13
进行中（未招募）
不适用
Sequential FLAMSA chemotherapy and T cell depleted reduced intensity conditioning allogeneic stem cell transplantation (TCD FLAMSA-RIC alloSCT) in elderly acute myeloid leukemia and high risk myelodysplasia patientsacute myeloid leukemia and high risk myelodysplasiaEUCTR2012-004421-24-NLeiden Universtity Medical Center
已完成
2 期
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell TransplantHodgkin's DiseaseNon Hodgkin's LymphomaMyelomaMyelodysplasiaLeukemiaNCT00597714David Rizzieri, MD264
进行中（未招募）
1 期
Alemtuzumab and Chemotherapyin T-cell-Lymphoma (ACT): CHOP-14 with or without the Monoclonal Anti-CD52 Antibody Alemtuzumab in Elderly Patients DSHNHL 2006-1B /ACT-2Patients 60 - 80 years old with newly diagnosed non cutanous, non leukemic Peripheral T- Cell lymphoma, except alk-protein positive anaplastic large cell lymphoma.MedDRA version: 16.0Level: PTClassification code 10042971Term: T-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-000821-23-DKFaculty of Medicine at the Georg-August University, Göttingen274
已完成
1 期
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic AnemiaAplastic AnemiaNCT01105273Asan Medical Center12